David Lebwohl, M.D.

David Lebwohl, M.D.

Executive Vice President, Chief Medical OfficeratIntellia Therapeutics· In proxies 2021–2025

Pay in FY2025-64% from the year before · Intellia Therapeutics stock -22.9% the same year

David Lebwohl, M.D. was paid $2.0M in FY2025 (Dec), down 64%. Intellia Therapeutics stock fell 22.9% that year.

Pay$100 in the stock at the end of FY20 → $17
Pay is from the Summary Compensation Table of each Intellia Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Intellia TherapeuticsPublic company · 5 yr
    • Executive Vice President, Chief Medical Officer2021 – Present · 5 yrStock in role -79%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?